Tweetable abstract Mitochondria are increasingly a target for drug delivery in cardiovascular diseases. This editorial describes how a nanomedicine approach may improve drug potency and efficacy in a safe and controlled manner.
Keywords: adenosine triphosphate; heart failure; ischemia/reperfusion injury; mitochondria; nanoparticles; reactive oxygen species.